, Tracking Stock Market Picks
Enter Symbol:
Autodesk, Inc. (ADSK) [hlAlert]

up 23.63 %

Autodesk, Inc. (ADSK) rated Buy with price target $52 by AmTech Research

Posted on: Thursday,  May 29, 2008  9:25 AM ET by AmTech Research

AmTech Research rated Buy Autodesk, Inc. (NASDAQ: ADSK) on 05/29/2008, when the stock price was $40.44. Since
then, Autodesk, Inc. has gained 23.64% as of 11/20/2015's recent price of $50.00.
If you would have followed this AmTech Research's recommendation on ADSK, you would have gained 23.63% of your investment in 2731 days.

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson?s disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.

Our focus is to generate profitable ideas through pure fundamental research. Our performance will be measured on the success of our recommendations at making money and saving money for our clients. Our objective is to be helpful during the investment process.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/29/2008 9:25 AM Buy
40.44 52.00
as of 12/24/2008
1 Week up  6.32 %
1 Month up  32.52 %
3 Months up  21.03 %
1 YTD up  0.15 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy